Archive for June 18th, 2009

Unusual Volume Alert: Smith & Wesson (SWHC)

Smith & Wesson Holding Corporation (NASDAQ: SWHC) is surging in after-hours.  The company discussed earnings, but it is making a diversification buyout to move into a new revenue segment.  As of 5:10 PM EST we have seen shares rise after a 2% gain to $4.93 in regular trading to an even higher price up 13% [...]

Aspen Biopharma rises on apparent FDA speculation (APPY)

Aspen Biopharma (Naddaq – APPY) shares are up more than 20% in Thursday trading on more than twice their normal volume, as traders appear to be anticipating FDA approval for the company’s AppyScore test that helps diagnose appendicitis. Aspen Bio previously had said it expects to file for FDA approval by end of the second quarter [...]

Maxim sees unusually bearish options activity

Maxim Integrated Circuit (MXIM) is down slightly on fairly mundane volume this afternoon, but the strong put buying is of note, given that the stock is one of analysts’ very favorite right now in the semiconductor group. Analyst sentiment for MXIM seemingly can’t get much higher, with estimate revisions on the rise and analyst ratings [...]

United Health gains as healthcare reform doubts creep (UNH)

United Healthcare (UNH) shares are up more than a point on stronger-than-usual volume for this time in the session, on speculation that President Obama will need to cede more ground to the private insurance system already in place in order to pass healthcare reform legislation. In the options market, calls are outnumbering puts at a [...]

Ge options are elevated, but it doesn't look like a bullish bet (GE)

General Electric shares have traded nearly a full-day’s volume and call buying in the options market is elevated; the call activity was among the most active for any stock in yesterday’s trading, as well. But the activity does not seem to be a bullish directional bet. It appears to be a professional trading strategy being [...]

Abbott shares break out, possibly on Humira sentiment

Shares of Abbott Labs are trading on slightly elevated volume for what’s normal in its first 45 minutes of trading, as the stock breaks above its May highs. There’s no news out on Abbott this morning and no meaningful analyst coverage. But the stock could be benefiting from positive technical patterns for the sector, market strength [...]

Matrixx rise premarket, company to address FDA letter (MTXX)

Matrixx Initiatives (MTXX) shares are up nearly 6% and among the most active premarket stocks after the company announced a conference call at 11 a.m. Eastern today to discuss the FDA warning letter that sent its shares tumbling in the previous session. On Wednesday, Matrix announced it had received an FDA warning letter that it [...]

YRC Worldwide gains premarket after pension deal (YRCW)

Trucker YRC Worldwide’s shares are up more than 3% on volume of more than 50,000 shares after it reached an agreement with several of its pension funds that will let the company use its real estate as collateral in lieu of making second-quarter pension contributions. The announcement may have been somewhat anticipated by the Street, [...]

Vical rises 10% premarket after reaching NIH milestones (VICL)

Vical (VICL) shares are up 10% premarket and have nearly traded a tenth of its average daily volume ahead of the open. The company announced this morning that has achieved second-year milestones under a 3-year, $6 million grant from the National Institutes of Health — a potential gateway to Vical getting more government funding. The [...]

Aastrom Bio shares surge after FDA removes hold on clinical trial (ASTM)

Aastrom Biosciences is a sub $1 stock, but it’s up about 35% in premarket trade after the company said the FDA removed the clinical hold from the company’s mid-stage trial of a treatment for congestive heart failure, allowing patient enrollment in trials to resume. The company’s Impact-DCM trial is evaluating the use of Cardiac Repair [...]